GSK plc (LON:GSK)
London · Delayed Price · Currency is GBP · Price in GBX 1,503.50
-14.00 (-0.92%)
Sep 12, 2025, 5:26 PM BST
GSK plc Market Cap
GSK plc has a market cap or net worth of 60.53 billion as of September 12, 2025. Its market cap has decreased by -10.44% in one year.
Market Cap
60.53B
Enterprise Value
73.83B
Revenue
31.63B
Ranking
n/a
PE Ratio
18.20
Stock Price
1,503.50
Market Cap Chart
Since December 27, 2000, GSK plc's market cap has decreased from 64.68B to 60.53B, a decrease of -6.42%. That is a compound annual growth rate of -0.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 61.11B | 11.22% |
| Dec 31, 2024 | 54.94B | -7.05% |
| Dec 29, 2023 | 59.11B | 1.25% |
| Dec 30, 2022 | 58.38B | -27.44% |
| Dec 31, 2021 | 80.46B | 20.44% |
| Dec 31, 2020 | 66.80B | -24.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 185.71B |
| Haleon | 32.24B |
| Smith & Nephew | 12.46B |
| ConvaTec Group | 4.88B |
| Hikma Pharmaceuticals | 3.74B |
| HUTCHMED (China) | 2.02B |
| Genus | 1.75B |
| Oxford Nanopore Technologies | 1.64B |